Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands - Wikidata - awgldk - TriplyDB

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

http://www.wikidata.org/entity/Q24655544

about

Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo Conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women.Microchip-based immunomagnetic detection of circulating tumor cells.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.Mechanisms of cancer cell metastasis to the bone: a multistep process.Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.Rethinking ovarian cancer: recommendations for improving outcomes.Isolation and characterization of circulating tumor cells in prostate cancer.High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles Mutation at the folate receptor 4 locus modulates gene expression profiles in the mouse uterus in response to periconceptional folate supplementation.A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis.Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.Isolated, disseminated and circulating tumour cells in prostate cancer.Circulating tumor cell assays for the prognosis of prostate and colon cancers.Enrichment, detection and clinical significance of circulating tumor cells.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Circulating tumor cell technologies.Near‑infrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes.Microfluidic platform for negative enrichment of circulating tumor cells.A label-free DC impedance-based microcytometer for circulating rare cancer cell counting.Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment.Metastasis and Circulating Tumor Cells.Efficient isolation and accurate in situ analysis of circulating tumor cells using detachable beads and a high-pore-density filter.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.

P2860

Q28388342-BA771093-9418-476F-A174-95ECC57699FC Q30442087-C85B7562-65A1-4396-886B-F9F408F61900 Q33583980-706EC066-ADF4-49F5-8EFE-6B81D7B3B805 Q34001559-491F48AD-2141-432E-8301-7D5B211EB303 Q34108738-3A33B4F2-49A7-487B-919D-BAD25302581F Q34122840-895C4FEF-12FC-4CDD-A070-4BBEF4032C70 Q34317709-02169202-CAF5-41AB-B47F-D77C38F9CCB7 Q34687073-B9B13B4C-17E4-4956-B709-EB43C4DB70CB Q35063733-1C2BC9ED-1CBF-41E4-9D8D-C2959214C849 Q35591666-D9EB6B59-325A-4883-BEF8-72B307E2A61A Q35673417-32FD1ABC-D7A2-4E4F-886B-1A2B1272D96F Q35913613-F66F2E55-F21C-4557-985A-E3580C324D6C Q36050883-82FC2C0F-0138-4769-A861-D09EFCC1F948 Q36310363-1992137B-DBE6-42D2-B000-2A1876BF94CA Q36532522-9B29EC3D-15D8-4DA0-8108-92CF2F26AD0D Q36714078-B0BEFA75-B63D-4A5A-BD08-F9FC1502DB33 Q36840545-F2200AD0-1B35-4393-AB10-013A37C70EB7 Q36957933-3FEB5CD9-0792-4319-A636-85AC2ADD752E Q37163333-BB4CDB32-F928-49AF-A70F-15DDABB078DD Q37258262-74E19339-482C-4ACE-BAC6-5D925118085B Q37324291-F44849A8-D1B9-4A13-B851-D5C8409A3A6A Q37474373-8EAB2310-64B8-4CAD-9DA3-927F07368528 Q37604323-038282C2-5584-412A-BF55-0DAC610FAE36 Q37626062-3C1476AC-9C4B-4937-ADA1-EEC3AFB7BF68 Q38024987-96661A7E-BA4A-4750-A9D1-0CD98403ECB4 Q38089067-1EEA3816-0D95-4587-A016-10EED17614FD Q38102590-587B68D8-FD81-4509-A562-21FB5B3B11FE Q38432883-FB5FCAAD-69DF-4397-8FF9-BE41CC030DD4 Q38742272-0CFFCFB6-6FC3-449E-90D4-44CD220A7C3E Q38944074-000B8619-F46C-4CB8-9756-D527BF5E3224 Q39011800-079059A9-EA5A-4CF3-83A4-B1B622940528 Q39206472-ABA9A31B-A4F6-4382-AEAF-ED54803FC4B8 Q39339880-FD99FCB3-85C7-4D42-8EC6-1F5BD2285BC2 Q39543380-A8E4A44F-3AEF-4953-8FB6-AB049D5E7715 Q41822137-7FAAE066-BFCE-4494-8CCE-3AC45195EAAB Q41872799-1874A7F1-EFB8-4DFD-BA69-FE016C054D00 Q44956814-2D4D298C-8480-40C2-83A9-DEF53026832F Q47094357-19388FBB-C11B-4334-8CA2-7B93BD5C4397 Q47104064-D80DBDDA-ED75-4771-94BC-A151F0D397A9 Q48096559-8CDC56F0-89A1-4F3E-AB02-BF7FF88DEFB8

P2860

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

http://www.wikidata.org/entity/Q24655544

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Quantitation of circulating tu ...... r-specific fluorescent ligands

@ast

Quantitation of circulating tu ...... r-specific fluorescent ligands

@en

Quantitation of circulating tu ...... r-specific fluorescent ligands

@nl

type

label

Quantitation of circulating tu ...... r-specific fluorescent ligands

@ast

Quantitation of circulating tu ...... r-specific fluorescent ligands

@en

Quantitation of circulating tu ...... r-specific fluorescent ligands

@nl

prefLabel

Quantitation of circulating tu ...... r-specific fluorescent ligands

@ast

Quantitation of circulating tu ...... r-specific fluorescent ligands

@en

Quantitation of circulating tu ...... r-specific fluorescent ligands

@nl

P1433

Q24655544-FC5B0AEB-E5E5-4FE9-91EB-FAD3AAFC61C7

P1476

Q24655544-4D7212F3-05E6-4F82-9A54-070A2091A324

P2093

Q24655544-21498103-F51D-44B0-9A85-7841FB2B10FC

Q24655544-2ACFB9E2-C815-43CD-941F-8A8752CDE385

Q24655544-3EF41E8E-2733-420B-8F6A-B71641F369C8

Q24655544-69595F5A-7404-4054-A710-B49423CC0A3A

Q24655544-7300CCEF-7E81-4241-B245-4F40180BDEF5

Q24655544-748DFD2A-2282-4D54-82B4-4A192593DCD9

Q24655544-7FB67DEF-9C48-41B3-88E1-2D740F2D610D

Q24655544-D6EA8179-E1C3-43D2-8586-FA96950C42E2

P2860

Q24655544-028A52FE-8698-4084-98E4-CC40B9EB11CA

Q24655544-0A16964B-C376-4D9D-BDF2-FCA83B1DE0CB

Q24655544-1AC04292-D096-489A-80D8-F24E365D53E4

Q24655544-206FDE26-1517-4630-8451-B7DE20E94D2C

Q24655544-21E74972-BA38-44BB-BAAB-E16F09131798

Q24655544-225A962C-C1B2-447C-A8B3-395200A748E5

Q24655544-29ECBC46-D66C-4829-B308-E41219648BB8

Q24655544-2E09CE36-7DBE-40D3-96D7-994E0A6DB55D

Q24655544-3194DA5C-9F96-4CE8-ABBC-FC71EA5E4934

Q24655544-36C2C0B0-F101-4FB0-9875-7DB66C99FC16

P304

Q24655544-187CE1F9-51CA-49E4-9022-8CA21B551224

P31

Q24655544-8C3AFBCB-7269-4BE4-8CC3-9E572A1EBECD

P3181

Q24655544-3314F72A-961B-40BC-9982-D408E54EC97E

P356

Q24655544-399565BA-4ED5-4BD8-9912-B535CE7CB63A

P407

Q24655544-252B650A-0679-425D-ACE6-B1A3A9812B2F

P433

Q24655544-91A0AD7A-915A-41B9-958E-242563B12F92

P478

Q24655544-E38CA82B-7235-47E8-B32A-DBF830C2ACB7

P577

Q24655544-5CBCA168-6E67-41D8-90AB-67F077B779A0

P5875

Q24655544-7371683A-6974-40DA-9E96-29831A31CAE6

P698

Q24655544-8BF6F124-DB28-41A0-986D-C9B0FD5B2534

P932

Q24655544-F57F2269-FF25-4877-8375-72FCD42023E5

P3181

P356

P1433

International Journal of Cancer

P1476

Quantitation of circulating tu ...... r-specific fluorescent ligands

@en

P2093

Franklyn G Prendergast

http://www.w3.org/2001/XMLSchema#string

George G Klee

http://www.w3.org/2001/XMLSchema#string

Kimberly R Kalli

http://www.w3.org/2001/XMLSchema#string

Lynn C Hartmann

http://www.w3.org/2001/XMLSchema#string

Philip S Low

http://www.w3.org/2001/XMLSchema#string

Robert J Amato

http://www.w3.org/2001/XMLSchema#string

Sumith A Kularatne

http://www.w3.org/2001/XMLSchema#string

Wei He

http://www.w3.org/2001/XMLSchema#string

P2860

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

Detection and characterization of carcinoma cells in the blood

Transcription of the dystrophin gene in human muscle and non-muscle tissue

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

A rare-cell detector for cancer.

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

CA 125 in benign gynecological conditions.

Detection of minimal residual disease in acute leukemia by flow cytometry.

Illegitimate transcription: transcription of any gene in any cell type

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.

P304

1968-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4503072

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/IJC.23717

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51432330

http://www.w3.org/2001/XMLSchema#string

P698

18661519

http://www.w3.org/2001/XMLSchema#string

P932

2778289

http://www.w3.org/2001/XMLSchema#string